Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Saturday, October 26, 2024.
Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
Long-Term Uptrend (+90) - PTGX is in a strong uptrend that is likely to continue. While PTGX is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid PTGX?
MarketClub looks at technical strength and momentum to determine if the timing is right for PTGX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for PTGX
The long-term trend has been UP since Dec 6th, 2023 at 20.225
The intermediate-term trend has been UP since Oct 15th, 2024 at 47.850
The short-term trend has been UP since Oct 24th, 2024 at 47.030
Smart Scan Analysis for PTGX
Based on our trend formula, PTGX is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 47.3000 | 47.9499 | 46.8350 | 47.2700 | +0.3200 |
| Prev. Close | Volume | Bid | Ask | Time |
| 47.2600 | 219707 | 2024-10-25 15:59:51 |
| Year High | 23.97 | Year High Date | 2018-03-09 |
| Year Low | 5.4927 | Year Low Date | 2018-11-28 |
| 52wk High | 48.3225 | 52wk High Date | 2024-10-15 |
| 52wk Low | 13.75 | 52wk Low Date | 2023-10-27 |
| Average Volume | 516,771 | Shares Outstanding | 58,905 |
| Market Cap | 372M | Assets | 614,629,000M |
| Liabilities | 73,305,000M | P/E Ratio | 17.3889 |
| Volatility | 79.58 |